TokenPost·
Scinai Immunotherapeutics Ltd. Posts 167% Revenue Growth Through September
The company’s net loss was $390,000, compared with $6.24 million in the year-earlier period.
More news
- The DefiantKeplr Pauses Google and Apple Login After Unauthorized Transaction Reports
- CryptoSlateEIP-8037 state-gas rules force Ethereum dApps to rewrite billing
- TokenPostBrockman Says OpenAI Could Be Ready to Go Public in 2027
- TokenPostCION Investment Lowers Quarterly Distribution 16.7% to $0.25
- TokenPostWormhole-Elysium Partnership Announced Ahead of Mainnet Launch
- TokenPostCardano Foundation Begins 10-Week Dublin Program for Eight Ventures